Vital Signs - Healthcare News - The Analysts Perspect March 2014 Issue
Vital Signs - Healthcare News - The Analysts Perspect March 2014 Issue
RELEASE DATE
31-Mar-2014
31-Mar-2014
REGION
North America
North America
Research Code: 9A35-00-12-00-00
SKU: LS00215-NA-MR_17480
$450.00
Special Price $337.50 save 25 %
In stock
SKU
LS00215-NA-MR_17480
Description
This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gilead's Sovaldi, Sony's genomic partnership with Illumina, and Craig Venter’s latest venture, Human Longevity, Inc.
Table of Contents
This Week's Issue
Related Research
Popular Topics
This issue of Vital Signs, released on March 31, 2014, discusses the premium price tag of Gileads Sovaldi, Sonys genomic partnership with Illumina, and Craig Venters latest venture, Human Longevity, Inc.
No Index | Yes |
---|---|
Podcast | No |
Author | Jennifer Lazar |
WIP Number | 9A35-00-12-00-00 |
Is Prebook | No |